BROMODOMAIN INHIBITORS

wherein Rx, Ry, Rx1, L1, G1, A1, A2, A3, and A4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutic...

Full description

Saved in:
Bibliographic Details
Main Authors DAI, Yujia, LIU, Dachun, WANG, Le, MARJANOVIC, Jasmina, MCDANIEL, Keith, SHEPPARD, George, FIDANZE, Steven D, HOLMS, James, HASVOLD, Lisa, MCCLELLAN, William
Format Patent
LanguageChinese
English
Published 28.07.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract wherein Rx, Ry, Rx1, L1, G1, A1, A2, A3, and A4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).
AbstractList wherein Rx, Ry, Rx1, L1, G1, A1, A2, A3, and A4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).
Author WANG, Le
DAI, Yujia
MCDANIEL, Keith
MCCLELLAN, William
HASVOLD, Lisa
MARJANOVIC, Jasmina
FIDANZE, Steven D
HOLMS, James
LIU, Dachun
SHEPPARD, George
Author_xml – fullname: DAI, Yujia
– fullname: LIU, Dachun
– fullname: WANG, Le
– fullname: MARJANOVIC, Jasmina
– fullname: MCDANIEL, Keith
– fullname: SHEPPARD, George
– fullname: FIDANZE, Steven D
– fullname: HOLMS, James
– fullname: HASVOLD, Lisa
– fullname: MCCLELLAN, William
BookMark eNrjYmDJy89L5WQQcwry9_V38fd19PRT8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfEe3oZGRsbGZiaOhsZEKAEAT1Ygmw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 布羅莫結構域抑制劑
ExternalDocumentID HK1223364A1
GroupedDBID EVB
ID FETCH-epo_espacenet_HK1223364A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:56:00 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HK1223364A13
Notes Application Number: HK20160111612
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170728&DB=EPODOC&CC=HK&NR=1223364A1
ParticipantIDs epo_espacenet_HK1223364A1
PublicationCentury 2000
PublicationDate 20170728
PublicationDateYYYYMMDD 2017-07-28
PublicationDate_xml – month: 07
  year: 2017
  text: 20170728
  day: 28
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies ABBVIE INC
RelatedCompanies_xml – name: ABBVIE INC
Score 3.2200606
Snippet wherein Rx, Ry, Rx1, L1, G1, A1, A2, A3, and A4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title BROMODOMAIN INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170728&DB=EPODOC&locale=&CC=HK&NR=1223364A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU5JA00GmeqmpZib6ZokmhvoAltFSbqGKWbmqaB7VA3TQPudff3MPEJNvCJMI5gYMmF7YcDnhJaDD0cE5qhkYH4vAZfXBYhBLBfw2spi_aRMoFC-vVuIrYsatHdsaG5gbmSh5uJk6xrg7-LvrObsbOvhreYXZGsIrAaNzUwcgR0lVlArGnTMvmuYE2hTSgFyjeImyMAWADQsr0SIgakqQ5iB0xl28ZowA4cvdL4byIRmvWIRBjGnIH9foG2-jp5-Cp5-Hp5OniH-QcGiDApuriHOHrpAC-Lhnon38IY7xViMgQXYx0-VYFAwMEgBHUSXlJqWZmqSaJialJZqamloam6SYpRinmycKMkgidMYKTxy0gxcoFABDUYaWcgwsJQUlabKAmvRkiQ5sP8BrQxzdg
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgRg3GEyMZw-ot4q-Mw4VWttVKV3bqRS0W9WujbYLTKwIiV-PU3WDC9yiRLITS47z2bENcKuVjAeDDImVxJT0nMgSvooKSSlNUvE-qgrj-c5hZNJn_XFuzDuw2ubCNHVCP5viiKhRC9T3urmv1z9OLLf5W7m5K1Y49fbgpZYrtuhYITJRR6JrW5NZ7MaO6DgWDcQosRQ0g5qpjxEo7RFEhA1SerF5Usr6t0XxjmB_hsRe62PofC370HO2jdf6cBC28W4ctqq3OYGBncQhcgvHfiT4EfVtP42Tp1MQvEnqUAkZZLvDZDTYbUUbQBcxfnUGgiyXvBBdUTFm6LlSFawy7hWD6KVakoWWD2H4J5nzf9ZuoEfTcJpN_Si4gEMuIe6YVEeX0K3fP6ortKh1cd3I4hs3RnZg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=BROMODOMAIN+INHIBITORS&rft.inventor=DAI%2C+Yujia&rft.inventor=LIU%2C+Dachun&rft.inventor=WANG%2C+Le&rft.inventor=MARJANOVIC%2C+Jasmina&rft.inventor=MCDANIEL%2C+Keith&rft.inventor=SHEPPARD%2C+George&rft.inventor=FIDANZE%2C+Steven+D&rft.inventor=HOLMS%2C+James&rft.inventor=HASVOLD%2C+Lisa&rft.inventor=MCCLELLAN%2C+William&rft.date=2017-07-28&rft.externalDBID=A1&rft.externalDocID=HK1223364A1